NASDAQ:OCDX Ortho Clinical Diagnostics (OCDX) Stock Price, News & Analysis → President Kamala (From Stansberry Research) (Ad) Free OCDX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$17.63▼$17.6350-Day Range$17.63▼$17.6352-Week Range$16.04▼$22.99Volume5,400 shsAverage Volume1.24 million shsMarket Capitalization$3.92 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Ortho Clinical Diagnostics alerts: Email Address Ad Paradigm PressDiscover How to Turn $10,000 into $1 MillionToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.That will slam shut June 25. About Ortho Clinical Diagnostics Stock (NASDAQ:OCDX)Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.Read More Ad Paradigm PressDiscover How to Turn $10,000 into $1 MillionToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.That will slam shut June 25. OCDX Stock News HeadlinesAugust 22, 2023 | investing.comNovacyt: Innovative Clinical DiagnosticsAugust 9, 2023 | cbsnews.comFirst long COVID treatment clinical trials from NIH getting underwayMarch 18, 2023 | finance.yahoo.comClinical Diagnostics Global Market Report 2023: Sector to Reach $124.7 Billion by 2028 at a CAGR of 8.56%February 25, 2023 | marketwatch.comClinical Diagnostics Mass Spectrometry Market Brief Analysis By Top Leading CompaniesFebruary 25, 2023 | marketwatch.comClinical Diagnostics Market 2023 is FASTEST-GROWING in [ Medical Devices & Consumables ] Sector till 2028February 22, 2023 | marketwatch.comClinical Diagnostics Market Size in 2023 Business Forecast 2028 by Discovering LATEST TRENDSFebruary 18, 2023 | seekingalpha.comChitogenX announces $3.5M grant to advance ORTHO-R commercial developmentJanuary 25, 2023 | marketwatch.comClinical Diagnostics Mass Spectrometry Market 2023 : Future Developments, Key Vendors, Regional Analysis and Industry Scope by 2029January 12, 2023 | finance.yahoo.comThe Worldwide Clinical Diagnostics Industry is Expected to Reach $93.6 Billion by 2027November 2, 2022 | finance.yahoo.comDr. James S. Lewis II, Antibiotic Susceptibility Test Expert, Joins as Chair of Selux Diagnostics' Clinical Advisory BoardOctober 14, 2022 | finance.yahoo.comGlobal Clinical Microbiology Instruments and Reagents Market Report 2022: Advancements in Molecular Diagnostics Drive GrowthSeptember 23, 2022 | finance.yahoo.comBrightInsight and bioMérieux Announce Partnership to Launch Clinical Digital Solutions for DiagnosticsMay 7, 2022 | seekingalpha.comOrtho Clinical Diagnostics Holdings PLC (OCDX) CEO Chris Smith on Q1 2022 Results - Earnings Call TranscriptMay 5, 2022 | fool.comOrtho Clinical Diagnostics Holdings plc (OCDX) Q1 2022 Earnings Call TranscriptMay 5, 2022 | seekingalpha.comOrtho Clinical Diagnostics Holdings plc 2022 Q1 - Results - Earnings Call PresentationMay 4, 2022 | finance.yahoo.comOrtho Clinical Diagnostics (OCDX) Q1 Earnings Top EstimatesMay 4, 2022 | seekingalpha.comOrtho Clinical Diagnostics Non-GAAP EPS of $0.23 beats by $0.03, revenue of $495M misses by $12.41MMay 4, 2022 | finance.yahoo.comOrtho Clinical Diagnostics Reports First Quarter 2022 ResultsApril 28, 2022 | finance.yahoo.comWhy Ortho Clinical (OCDX) Could Beat Earnings Estimates AgainApril 27, 2022 | finance.yahoo.comOrtho Clinical Diagnostics (OCDX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseApril 26, 2022 | finance.yahoo.comOrtho Clinical Diagnostics Recognized with Fifth Prestigious Edison Award for Highly Accurate COVID-19 SolutionApril 20, 2022 | finance.yahoo.comOrtho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022March 24, 2022 | finance.yahoo.comOrtho Clinical (OCDX) Upgraded to Strong Buy: Here's What You Should KnowMarch 11, 2022 | finance.yahoo.comWall Street Analysts Predict a 58% Upside in Ortho Clinical (OCDX): Here's What You Should KnowMarch 9, 2022 | finance.yahoo.comOrtho Clinical Diagnostics Wins Bronze Stevie® Award for Customer Service and SupportSee More Headlines Receive OCDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ortho Clinical Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/03/2021Today6/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic Substances Sub-IndustryN/A Current SymbolNASDAQ:OCDX CUSIPN/A CIK1828443 Webwww.orthoclinicaldiagnostics.com Phone908-218-8000FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E Ratio21.77 P/E Growth1.66Net Income$-54,300,000.00 Net Margins-0.02% Pretax Margin1.38% Return on Equity41.71% Return on Assets5.10% Debt Debt-to-Equity Ratio4.91 Current Ratio1.89 Quick Ratio1.29 Sales & Book Value Annual Sales$2.04 billion Price / Sales1.92 Cash Flow$2.28 per share Price / Cash Flow7.73 Book Value$1.99 per share Price / Book8.86Miscellaneous Outstanding Shares222,585,000Free FloatN/AMarket Cap$3.92 billion OptionableNot Optionable Beta1.32 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Christopher Michael Smith (Age 59)Chairman & CEO Comp: $2.85MMr. Joseph M. Busky CPA (Age 54)Chief Financial Officer Comp: $607.06kMr. Michael A. Schlesinger (Age 63)Exec. VP, Gen. Counsel & Sec. Comp: $879.13kMr. Michael S. Iskra (Age 52)Exec. VP of Commercial Excellence & Strategy Comp: $760.23kDr. Chockalingam Palaniappan Ph.D. (Age 57)Chief Innovation Officer Comp: $826.63kMs. Ariane SchiereckChief Information OfficerMr. Marwan FathallahHead of Quality, Regulatory, Compliance, Clinical, Medical & Scientific AffairsMr. Gary PassmanHead of People & CultureKaren TaylorHead of Global Commercial EnablementMr. Warren StoneHead of AmericasMore ExecutivesKey CompetitorsHaemoneticsNYSE:HAELantheusNASDAQ:LNTHNeogenNASDAQ:NEOGQuidelOrthoNASDAQ:QDELCelldex TherapeuticsNASDAQ:CLDXView All Competitors OCDX Stock Analysis - Frequently Asked Questions How were Ortho Clinical Diagnostics' earnings last quarter? Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) announced its earnings results on Wednesday, November, 3rd. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.07. The business had revenue of $522.50 million for the quarter, compared to the consensus estimate of $485.36 million. Ortho Clinical Diagnostics had a negative net margin of 0.02% and a positive trailing twelve-month return on equity of 41.71%. When did Ortho Clinical Diagnostics IPO? Ortho Clinical Diagnostics (OCDX) raised $1.5 billion in an IPO on Thursday, January 28th 2021. The company issued 70,000,000 shares at $20.00-$23.00 per share. J.P. Morgan, BofA Securities, Goldman Sachs, Barclays and Morgan Stanley served as the underwriters for the IPO and Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, Piper Sandler, ING, Macquarie Capital, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright & Co., Ramirez & Co. and Siebert Williams Shank were co-managers. This page (NASDAQ:OCDX) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ortho Clinical Diagnostics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Ortho Clinical Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.